Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 20/20 | 0.77 |
| ▸ | PIK3CG | P48736 | 16/20 | 0.77 |
| ▸ | PIK3R1 | P27986 | 7/20 | 0.77 |
| ▸ | PIK3CA | P42336 | 7/20 | 0.62 |
| ▸ | PIK3CB | P42338 | 6/20 | 0.62 |
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8873 | 0.91 | PIK3CD (0.78) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL14749 | 0.90 | PIK3CD (0.83) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655821 | 0.89 | PIK3CD (0.87) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9212 | 0.89 | PIK3CD (0.87) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL14694 | 0.89 | PIK3CD (0.76) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655782 | 0.89 | PIK3CD (0.76) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9343 | 0.89 | PIK3CD (0.86) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9272 | 0.87 | PIK3CD (1.00) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655838 | 0.87 | PIK3CD (1.00) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL28547783 | 0.87 | PIK3CD (0.83) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112516179-A | Dosing regimens and formulations for adenovirus type B | 普赛奥克苏斯治疗公司 | 2021-03-19 | — | — | CN | disclosed |